Category: Latest News

Marvell Technology (NASDAQ:MRVL) slid 6% on Monday amid growing concerns that the semiconductor firm may be losing key hyperscaler design wins. The drop followed a report indicating Microsoft (NASDAQ:MSFT) is exploring future custom chip development with Broadcom (NASDAQ:AVGO), as well as a downgrade from Benchmark over worries about Amazon (NASDAQ:AMZN) shifting away from Marvell. According…

Kymera Therapeutics (NASDAQ:KYMR) jumped 16% on Monday after the company reported promising early-stage clinical results for KT-621, its oral STAT6 degrader being developed for moderate to severe atopic dermatitis. Data from the Phase 1b BroADen study showed that KT-621 delivered substantial STAT6 degradation in both the 100 mg and 200 mg dosing groups, with median…

Kamada Ltd. (NASDAQ:KMDA) fell 8% on Monday after the company said it is discontinuing its Phase 3 trial evaluating its inhaled Alpha-1 Antitrypsin (AAT) therapy for treating Alpha-1 Antitrypsin Deficiency (AATD). The move came after guidance from an independent Data and Safety Monitoring Board, which concluded the study was unlikely to reach statistical significance on…

Fulcrum Therapeutics (NASDAQ:FULC) soared 50% on Monday after unveiling upbeat preliminary findings from its Phase 1b PIONEER study evaluating pociredir in patients with sickle cell disease. The biotech reported that the 20 mg cohort delivered a strong increase in fetal hemoglobin (HbF). By Week 6, mean absolute HbF had risen 9.9%—notably higher than the 5.6%…

Agios Pharmaceuticals (NASDAQ:AGIO) dropped 7% after revealing that the U.S. Food and Drug Administration has yet to issue a ruling on its supplemental New Drug Application (sNDA) for mitapivat. The filing seeks expanded approval for mitapivat to treat adults with both non–transfusion-dependent and transfusion-dependent forms of alpha- and beta-thalassemia. Although the application cleared its Prescription…

Strategy Inc. (NASDAQ:MSTR) revealed on Dec. 8, 2025, that it bought an additional 10,624 Bitcoin (COIN:BTCUSD) between Dec. 1 and Dec. 7, spending roughly $962.7 million. The company said the purchases were executed at an average price of $90,615 per coin. The acquisition was funded through proceeds raised under Strategy’s at-the-market (ATM) equity offering program.…

Shares of Confluent Inc. (NASDAQ:CFLT) surged in premarket trading Monday after a Wall Street Journal report said International Business Machines (IBM) is close to sealing an $11 billion takeover of the data infrastructure company. By 06:15 ET, Confluent stock was up 28.1%. According to the report, the two sides could announce a deal as early…

Berkshire Hathaway Inc. (NYSE:BRK.B) unveiled a series of organizational changes as longtime chief executive Warren Buffett approaches his planned departure at the end of 2025. One of the most notable updates is the upcoming exit of Todd Combs, who has been both an investment manager at Berkshire and the CEO of GEICO. Combs will depart…

Eli Lilly’s (NYSE:LLY) blockbuster diabetes treatment Mounjaro is set to become part of China’s state medical insurance system beginning January 1, the National Healthcare Security Administration announced on Sunday. The decision means the once-weekly injectable will be reimbursable for adults with type 2 diabetes. Its inclusion is expected to broaden access across China’s population of…